Clinical Trial Update: A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM [Phase 1]

View source ↗

Summary

A Phase 1 feasibility trial is evaluating the safety of the TheraSphere Glioblastoma Device in patients with recurrent glioblastoma; the study is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• TheraSphere Glioblastoma Device

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Glioblastoma Multiforme, Recurrent Glioblastoma | Phase 1 | Status: RECRUITING